Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

CYPHCYPH
8 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in LEAP THERAPEUTICS INC

Yes. Two Sigma holds 80,411 shares of CYPH (Leap Therapeutics), worth $49,236, as of its Q2 2026 13F filing. It increased the position by 13,839 shares (+20.8%) from Q1 2026. Two Sigma has held CYPH since Q1 2025, across 6 quarterly 13F filings.

Current Value

$49,236

Current Shares

80,411

Total Value Change

+$3,521

Total Shares Change

+57,087

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
80,411
+20.8%
$49,2360.0%$0.61
17
2026-Q1
Decreased
66,572
-7.8%
$52,8980.0%$0.80
0
2025-Q4
Increased
72,172
+1.9%
$83,7200.0%$1.16
22
2025-Q3
Increased
70,849
+409.8%
$32,1650.0%$0.45
22
2025-Q2
Increased
13,897
+8.3%
$4,1260.0%$0.30
11
2025-Q1
New
12,838
-
$3,9170.0%$0.31
22
2024-Q3
Exited
0
-100.0%
$00.0%$2.57
0
2024-Q2
New
23,324
-
$45,7150.0%$1.96
28

Other major holders of CYPH: BALYASNY ASSET MANAGEMENT L.P., BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used